Literature DB >> 16054243

Quantitation of feline leukaemia virus viral and proviral loads by TaqMan real-time polymerase chain reaction.

Ravi Tandon1, Valentino Cattori, Maria Alice Gomes-Keller, Marina L Meli, Matthew C Golder, Hans Lutz, Regina Hofmann-Lehmann.   

Abstract

Feline leukaemia virus (FeLV) infection in cats is not only of veterinary importance but also a well-acknowledged animal model for studying the pathogenesis of retroviral disease. After virus exposure, different courses and outcomes of FeLV infection may prevail; they have been associated with cellular and humoral immune responses and the FeLV proviral load in peripheral blood. We hypothesized that the plasma viral RNA load might be an additional relevant indicator for the infection outcome. To quantify these loads, a real-time reverse transcriptase (RT) polymerase chain reaction (PCR) assay was developed. The assay amplifies FeLV-A, -B, and -C as some naturally infected cats could not be identified with a FeLV-A-based assay previously. The assay was applied to determine plasma FeLV RNA loads in cats infected both naturally and experimentally with FeLV. In addition, an improved real-time PCR assay for quantitation of FeLV proviral loads is described. The assays developed were more sensitive than ELISA and virus isolation in the early phase of infection. In addition, PCR allows the identification of provirus carriers that have overcome antigenaemia. Thus, for most effective detection of FeLV exposure and characterization of the infection in a cat, PCR assays are recommended as diagnostic tools.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054243     DOI: 10.1016/j.jviromet.2005.06.017

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  54 in total

1.  Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines.

Authors:  Hervé Poulet; Jean-Christophe Thibault; Alonso Masias
Journal:  Clin Vaccine Immunol       Date:  2015-12

2.  Prevalence, risk factor analysis, and follow-up of infections caused by three feline hemoplasma species in cats in Switzerland.

Authors:  Barbara Willi; Felicitas S Boretti; Claudia Baumgartner; Séverine Tasker; Bettina Wenger; Valentino Cattori; Marina L Meli; Claudia E Reusch; Hans Lutz; Regina Hofmann-Lehmann
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

3.  Identification, molecular characterization, and occurrence of two bovine hemoplasma species in Swiss cattle and development of real-time TaqMan quantitative PCR assays for diagnosis of bovine hemoplasma infections.

Authors:  Marina L Meli; Barbara Willi; Ute M Dreher; Valentino Cattori; Gabriela Knubben-Schweizer; Karl Nuss; Ueli Braun; Hans Lutz; Regina Hofmann-Lehmann
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

4.  In situ hybridization of feline leukemia virus in a primary neural B-cell lymphoma.

Authors:  Anna Szilasi; Lilla Dénes; Csaba Jakab; Ildikó Erdélyi; Talita Resende; Fabio Vannucci; Judit Csomor; Míra Mándoki; Gyula Balka
Journal:  J Vet Diagn Invest       Date:  2020-04-10       Impact factor: 1.279

5.  Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland.

Authors:  Maya Kummrow; Marina L Meli; Michael Haessig; Enikoe Goenczi; Amy Poland; Niels C Pedersen; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

6.  Feline leukemia virus immunity induced by whole inactivated virus vaccination.

Authors:  Andrea N Torres; Kevin P O'Halloran; Laurie J Larson; Ronald D Schultz; Edward A Hoover
Journal:  Vet Immunol Immunopathol       Date:  2009-10-31       Impact factor: 2.046

7.  Dominance of highly divergent feline leukemia virus A progeny variants in a cat with recurrent viremia and fatal lymphoma.

Authors:  A Katrin Helfer-Hungerbuehler; Valentino Cattori; Felicitas S Boretti; Pete Ossent; Paula Grest; Manfred Reinacher; Manfred Henrich; Eva Bauer; Kim Bauer-Pham; Eva Niederer; Edgar Holznagel; Hans Lutz; Regina Hofmann-Lehmann
Journal:  Retrovirology       Date:  2010-02-19       Impact factor: 4.602

8.  A targeted mutation within the feline leukemia virus (FeLV) envelope protein immunosuppressive domain to improve a canarypox virus-vectored FeLV vaccine.

Authors:  Géraldine Schlecht-Louf; Marianne Mangeney; Hanane El-Garch; Valérie Lacombe; Hervé Poulet; Thierry Heidmann
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

9.  Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection.

Authors:  Andrea Major; Valentino Cattori; Eva Boenzli; Barbara Riond; Peter Ossent; Marina Luisa Meli; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Vet Res       Date:  2009-10-28       Impact factor: 3.683

10.  In vivo transmission studies of 'Candidatus Mycoplasma turicensis' in the domestic cat.

Authors:  Kristina Museux; Felicitas S Boretti; Barbara Willi; Barbara Riond; Katharina Hoelzle; Ludwig E Hoelzle; Max M Wittenbrink; Séverine Tasker; Nicole Wengi; Claudia E Reusch; Hans Lutz; Regina Hofmann-Lehmann
Journal:  Vet Res       Date:  2009-05-16       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.